News Daily News Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes? Yael L. Maxwell December 10, 2018
News Features The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine Shelley Wood October 22, 2018
News Conference News SCAI 2018 ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended L.A. McKeown April 26, 2018